Institutional Accredited Investor or Qualified Institutional Buyer. The Holder is either (i) an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), or (ii) a “qualified institutional buyer” within the meaning of Rule 144A promulgated under the Securities Act.
Appears in 4 contracts
Samples: Exchange Agreement (Amicus Therapeutics, Inc.), Exchange Agreement (Amicus Therapeutics, Inc.), Exchange Agreement (Amicus Therapeutics, Inc.)
Institutional Accredited Investor or Qualified Institutional Buyer. The Holder is either (i) an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), or (ii) a “qualified institutional buyer” within the meaning of Rule 144A promulgated under the Securities Act.
Appears in 3 contracts
Samples: Term Loan Framework Agreement (McClatchy Co), Term Loan Framework Agreement (McClatchy Co), Term Loan Framework Agreement (McClatchy Co)
Institutional Accredited Investor or Qualified Institutional Buyer. The Each Holder is either either: (ia) an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), ) or (iib) a “qualified institutional buyer” within the meaning of Rule 144A promulgated under the Securities Act.
Appears in 3 contracts
Samples: Convertible Notes Exchange Agreement (Biora Therapeutics, Inc.), Convertible Notes Exchange Agreement (Biora Therapeutics, Inc.), Convertible Notes Exchange Agreement (Assertio Holdings, Inc.)
Institutional Accredited Investor or Qualified Institutional Buyer. The Holder Such Purchaser is either either: (ia) an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), ) or (iib) a “qualified institutional buyer” within the meaning of Rule 144A promulgated under the Securities Act.
Appears in 2 contracts
Samples: Convertible Notes Purchase Agreement (Biora Therapeutics, Inc.), Convertible Notes Purchase Agreement (Biora Therapeutics, Inc.)
Institutional Accredited Investor or Qualified Institutional Buyer. The Such Holder is either either: (ia) an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), ) or (iib) a “qualified institutional buyer” within the meaning of Rule 144A promulgated under the Securities Act.
Appears in 1 contract
Samples: Convertible Notes Exchange Agreement (Biora Therapeutics, Inc.)
Institutional Accredited Investor or Qualified Institutional Buyer. The Holder is either either: (ia) an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), ) or (iib) a “qualified institutional buyer” within the meaning of Rule 144A promulgated under the Securities Act.
Appears in 1 contract
Samples: Convertible Notes Exchange Agreement (Biora Therapeutics, Inc.)
Institutional Accredited Investor or Qualified Institutional Buyer. The Holder Lender is either (i) an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3), (7) or (7) 8) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), or (ii) a “qualified institutional buyer” within the meaning of Rule 144A promulgated under the Securities Act.
Appears in 1 contract
Samples: Loan and Security Agreement (Spring Bank Pharmaceuticals, Inc.)
